If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Valganciclovir Related compound G
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1356353-76-8Valganciclovir Related compound G

● Under Development

Catalogue No.:VE006218
CAS No.:1356353-76-8
Mol. Formula:C15H24N6O6
Mol. Weight:384.39

Additional information on CAS 1356353-76-8

Parent drug

Valganciclovir

IUPAC Name

L-Valine 2-[[(2-amino-1, 6-dihydro-6-oxo-9H-purin-9-yl)methoxy]methoxy]-3-hydroxypropyl ester

Synonyms

Valganciclovir Homolog

Description

Also known as Valganciclovir Homolog, it may be found as an impurity in the synthesis of Valganciclovir. Valganciclovir is an L-valyl ester prodrug of ganciclovir. It is used as prophylactic antiviral therapy for the treatment of Cytomegalovirus and is also used in patients who have impaired immune systems.

References

Singh, Onkar, et al. “Determination of Valganciclovir and Ganciclovir in Human Plasma by Liquid Chromatography Tandem Mass Spectrometric Detection.†Clinical Biochemistry, vol. 44, no. 10-11, July 2011, pp. 907–15, https://doi.org/10.1016/j.clinbiochem.2011.04.003. ?“Synthesis of Valganciclovir Hydrochloride Congeners.†Synthetic Communications, 2013, www.tandfonline.com/doi/abs/10.1080/00397911.2011.651249. ?

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form